Global Alopecia Treatment Market: By Alopecia Type (Alopecia Areata, Alopecia Totalis, and Others), By Treatment Type (Topical Drugs (Creams, Oils, Lotions, Gels, Shampoos, and Foams), Oral Drugs, and Injectables (Platelet Rich Plasma Therapy, Steroids and Injectable Fillers)), By End User (Hospitals, Dermatology and Trichology Clinics, Home Care Settings, and Aesthetic Clinics), and Geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
Global Alopecia Treatment Market Report Description:
Global alopecia treatment market report gives comprehensive outlook on alopecia treatment across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on alopecia treatment market gives historical, current, and future market sizes (US$ Mn) on the basis of alopecia type, treatment type, end user, and geographic regions. This report studies alopecia treatment market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, alopecia treatment market report includes new product introductions; regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed alopecia treatment market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Treatment Opportunities). Key stakeholders of the alopecia treatment market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in manufacturing, supply and prescribing of alopecia treatment products.
Global Alopecia Treatment Market:
Global alopecia treatment market estimated to be valued US$ 7,776 Mn in 2017 and poised to grow at CAGR of 6.0% over 2017-2023. Market for alopecia treatment projected to reach US$ 11,056 Mn by 2023 owing to increasing incidence of hair fall and lifestyle across the geographic regions.
Rising disposable income couples with increased emphasis in aesthetic appearance expected to drive market growth over the forecast period
The rise in disposable income and out-of-pocket healthcare expenditure in several developing and developed economies has created the market demand for alopecia treatment products across the globe. Increase in disposable income has prompted the patients to seek better treatment options for alopecia and several other diseases. Moreover, the rise in alopecia awareness among young population owing to targeted marketing campaigns by several multinational players is expected to drive alopecia treatment market over the forecast period. Moreover, increasing focus on aesthetic appearance among younger generation is projected to create market demand for the alopecia treatment products across the globe.
Drugs with superior efficacy expected to create lucrative market opportunity for the players
The market demand for alopecia treatment drugs are expected to increase owing to availability of wide variety of treatment options. Of late large number of alopecia treatment are preferring better efficacious and result driven products like cytokine and regenerative therapies for the treatment owing to enhanced results of aforementioned preparations in hair regrowth. Moreover, usage and availability of combination therapies are resulting into better treatment outcomes in several patients, which are expected to drive market revenue growth over the forecast period.
North America accounts for larger revenue share in global alopecia treatment market
North America market holds the higher revenue share in global alopecia treatment market and projected to remain same over the forecast period owing to rising disposable income and availability of wider treatment choices in the region. Asia-pacific alopecia treatment market projected to grow at significant CAGR over the forecast period in comparison with other regions owing to large patient population.
COMPETITION ASSESSMENT
Key players profiles in the global alopecia treatment market include:
KEY FINDINGS OF THE REPORT:
By Alopecia Type
Global alopecia treatment market report gives comprehensive outlook on alopecia treatment across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on alopecia treatment market gives historical, current, and future market sizes (US$ Mn) on the basis of alopecia type, treatment type, end user, and geographic regions. This report studies alopecia treatment market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, alopecia treatment market report includes new product introductions; regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed alopecia treatment market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Treatment Opportunities). Key stakeholders of the alopecia treatment market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in manufacturing, supply and prescribing of alopecia treatment products.
Global Alopecia Treatment Market:
Global alopecia treatment market estimated to be valued US$ 7,776 Mn in 2017 and poised to grow at CAGR of 6.0% over 2017-2023. Market for alopecia treatment projected to reach US$ 11,056 Mn by 2023 owing to increasing incidence of hair fall and lifestyle across the geographic regions.
Rising disposable income couples with increased emphasis in aesthetic appearance expected to drive market growth over the forecast period
The rise in disposable income and out-of-pocket healthcare expenditure in several developing and developed economies has created the market demand for alopecia treatment products across the globe. Increase in disposable income has prompted the patients to seek better treatment options for alopecia and several other diseases. Moreover, the rise in alopecia awareness among young population owing to targeted marketing campaigns by several multinational players is expected to drive alopecia treatment market over the forecast period. Moreover, increasing focus on aesthetic appearance among younger generation is projected to create market demand for the alopecia treatment products across the globe.
Drugs with superior efficacy expected to create lucrative market opportunity for the players
The market demand for alopecia treatment drugs are expected to increase owing to availability of wide variety of treatment options. Of late large number of alopecia treatment are preferring better efficacious and result driven products like cytokine and regenerative therapies for the treatment owing to enhanced results of aforementioned preparations in hair regrowth. Moreover, usage and availability of combination therapies are resulting into better treatment outcomes in several patients, which are expected to drive market revenue growth over the forecast period.
North America accounts for larger revenue share in global alopecia treatment market
North America market holds the higher revenue share in global alopecia treatment market and projected to remain same over the forecast period owing to rising disposable income and availability of wider treatment choices in the region. Asia-pacific alopecia treatment market projected to grow at significant CAGR over the forecast period in comparison with other regions owing to large patient population.
COMPETITION ASSESSMENT
Key players profiles in the global alopecia treatment market include:
- Cellmid Ltd. (Australia)
- Cipla Ltd. (India)
- Dr. Reddy’s Laboratories Ltd. (India)
- Johnson & Johnson Services, Inc. (U.S)
- Merck & Co., Inc. (U.S)
- Phyto Ales Group (France)
- Shiseido Co., Ltd.(Japan)
- Sun Pharmaceutical Industries Ltd. (India)
- Taisho Pharmaceutical Holdings Co., Ltd (Japan)
- Teva Pharmaceutical Industries Ltd. (Israel)
- The Himalaya Drug Company (India)
- Vitabiotics (U.K)
KEY FINDINGS OF THE REPORT:
- Global alopecia treatment market expanding at 6.0% CAGR over 2017 to 2023 to reach market value of US$ 11,056 Mn by 2023
- Based on treatment type, topical drugs accounted for larger market revenue share in 2016 owing to wider accessibility across the regions
- Dermatology and trichology clinics accounted for larger market revenue share in 2016 expected to remain attractive over the forecast period
- Players focusing on launching products expand market presence in global alopecia treatment market.
- The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
By Alopecia Type
- Alopecia Areata
- Alopecia Totalis
- Others
- Topical Drugs
- Creams
- Oils
- Lotions
- Gels
- Shampoos
- Foams
- Oral Drugs
- Injectables
- Platelet Rich Plasma Therapy
- Steroids
- Injectable Fillers
- Hospitals
- Dermatology and Trichology Clinics
- Home Care Settings
- Aesthetic Clinics
- North America
- U.S
- Canada
- Europe
- Germany
- France
- U.K
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia & New Zealand
- ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Venezuela
- Rest of Latin America
- Middle East and Africa (MEA)
- Gulf Cooperation Council (GCC) Countries
- Israel
- South Africa
- Rest of MEA
1. RESEARCH METHODOLOGY
1.1. Secondary and Primary research
1.1.1. Secondary Sources
1.1.2. Primary Sources
1.2. Market Revenue Estimation Methodology
1.3. Key Assumptions
1.4. Acronyms
2. SCOPE OF STUDY
2.1. Market Definition
2.2. Objective of the Research
2.3. Regions covered in the study
3. EXECUTIVE SUMMARY
4. GLOBAL ALOPECIA TREATMENT MARKET DYNAMICS
4.1. Drivers
4.1.1. Economic Drivers
4.1.2. Demand Side Drivers
4.1.3. Supply Side Drivers
4.2. Restraints
4.3. Opportunities/Unmet Needs of the Market
4.4. Trends
5. UNIQUE FEATURES OF THE REPORT
5.1. Competition analysis
5.2. Regulatory landscape
5.3. PESTLE analysis
5.4. Porter’s analysis
6. GLOBAL ALOPECIA TREATMENT MARKET ANALYSIS, BY ALOPECIA TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Alopecia Areata
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.2. Alopecia Totalis
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.3. Others Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.3.1. Year-over-Year (Y-o-Y) Growth Analysis (%)
7. GLOBAL ALOPECIA TREATMENT MARKET ANALYSIS, BY TREATMENT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Topical Drugs (Creams, Oils, Lotions, Gels, Shampoos and Foams)
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.2. OTC
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.3. Injectable (Platelet Rich Plasma Therapy, Steroids, Injectable Fillers)
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8. GLOBAL ALOPECIA TREATMENT MARKET FORECAST, BY END USER ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. Hospitals
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.2. Dermatology and Trichology Clinics
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.3. Home Care Settings
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.4. Aesthetic Clinics
8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9. ALOPECIA TREATMENT MARKET ANALYSIS, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1. North America Alopecia Treatment Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
9.1.1. Alopecia Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.1.1.1. Alopecia Areata
9.1.1.2. Alopecia Totalis
9.1.1.3. Others
9.1.2. Treatment Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.1.2.1. Topical Drugs (Creams, Oils, Lotions, Gels, Shampoos and Foams)
9.1.2.2. Oral Drugs
9.1.2.3. Injectable (Platelet Rich Plasma Therapy, Steroids, Injectable Fillers)
9.1.3. End User Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.1.3.1. Hospitals
9.1.3.2. Dermatology and Trichology Clinics
9.1.3.3. Home Care Settings
9.1.3.4. Aesthetic Clinics
9.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.1.4.1. U.S.
9.1.4.2. Canada
9.2. Europe Alopecia Treatment Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
9.2.1. Alopecia Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.2.1.1. Alopecia Areata
9.2.1.2. Alopecia Totalis
9.2.1.3. Others
9.2.2. Treatment Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.2.2.1. Topical Drugs (Creams, Oils, Lotions, Gels, Shampoos and Foams)
9.2.2.2. Oral Drugs
9.2.2.3. Injectable (Platelet Rich Plasma Therapy, Steroids, Injectable Fillers)
9.2.3. End User Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.2.3.1. Hospitals
9.2.3.2. Dermatology and Trichology Clinics
9.2.3.3. Home Care Settings
9.2.3.4. Aesthetic Clinics
9.2.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.2.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.2.5.1. U.K
9.2.5.2. Germany
9.2.5.3. France
9.2.5.4. Italy
9.2.5.5. Spain
9.2.5.6. Russia
9.2.5.7. Poland 9.2.5.8. Rest of Europe
9.3. Asia-Pacific Alopecia Treatment Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
9.3.1. Alopecia Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.3.1.1. Alopecia Areata
9.3.1.2. Alopecia Totalis
9.3.1.3. Others
9.3.2. Treatment Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.3.2.1. Topical Drugs (Creams, Oils, Lotions, Gels, Shampoos and Foams)
9.3.2.2. Oral Drugs
9.3.2.3. Injectable (Platelet Rich Plasma Therapy, Steroids, Injectable Fillers)
9.3.3. End User Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.3.3.1. Hospitals
9.3.3.2. Dermatology and Trichology Clinics
9.3.3.3. Home Care Settings
9.3.3.4. Aesthetic Clinics
9.3.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.3.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.3.5.1. Japan
9.3.5.2. China
9.3.5.3. India
9.3.5.4. ASEAN
9.3.5.5. Australia & New Zealand 9.3.5.6. Rest of Asia-Pacific
9.4. Latin America Acne Treatment Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
9.4.1. Alopecia Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.4.1.1. Alopecia Areata
9.4.1.2. Alopecia Totalis
9.4.1.3. Others
9.4.2. Treatment Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.4.2.1. Topical Drugs (Creams, Oils, Lotions, Gels, Shampoos and Foams)
9.4.2.2. Oral Drugs
9.4.2.3. Injectable (Platelet Rich Plasma Therapy, Steroids, Injectable Fillers)
9.4.3. End User Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.4.3.1. Hospitals
9.4.3.2. Dermatology and Trichology Clinics
9.4.3.3. Home Care Settings
9.4.3.4. Aesthetic Clinics
9.4.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.4.4.1. Brazil
9.4.4.2. Mexico
9.4.4.3. Argentina
9.4.4.4. Venezuela
9.4.4.5. Rest of Latin America
9.5. Middle East & Africa (MEA) Alopecia Treatment Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
9.5.1. Alopecia Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.5.1.1. Alopecia Areata
9.5.1.2. Alopecia Totalis
9.5.1.3. Others
9.5.2. Treatment Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.5.2.1. Topical Drugs (Creams, Oils, Lotions, Gels, Shampoos and Foams)
9.5.2.2. Oral Drugs
9.5.2.3. Injectable (Platelet Rich Plasma Therapy, Steroids, Injectable Fillers)
9.5.3. End User Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.5.3.1. Hospitals
9.5.3.2. Dermatology and Trichology Clinics
9.5.3.3. Home Care Settings
9.5.3.4. Aesthetic Clinics
9.5.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.5.4.1. Gulf Cooperation Council (GCC) Countries
9.5.4.2. Israel
9.5.4.3. South Africa
9.5.4.4. Rest of MEA
10. COMPETITION LANDSCAPE
10.1. Strategic Dashboard of Top Market Players
10.2. Company Profiles (Introduction, Financial Analysis, Alopecia & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
10.2.1. Cellmid Ltd. (Australia)
10.2.2. Cipla Ltd. (India)
10.2.3. Dr. Reddy’s Laboratories Ltd. (India)
10.2.4. Johnson & Johnson Services, Inc. (U.S)
10.2.5. Merck & Co., Inc. (U.S)
10.2.6. Phyto Ales Group (France)
10.2.7. Shiseido Co., Ltd.(Japan)
10.2.8. Sun Pharmaceutical Industries Ltd. (India)
10.2.9. Taisho Pharmaceutical Holdings Co., Ltd (Japan)
10.2.10. Teva Pharmaceutical Industries Ltd. (Israel)
10.2.11. The Himalaya Drug Company (India)
10.2.12. Vitabiotics (U.K)
1.1. Secondary and Primary research
1.1.1. Secondary Sources
1.1.2. Primary Sources
1.2. Market Revenue Estimation Methodology
1.3. Key Assumptions
1.4. Acronyms
2. SCOPE OF STUDY
2.1. Market Definition
2.2. Objective of the Research
2.3. Regions covered in the study
3. EXECUTIVE SUMMARY
4. GLOBAL ALOPECIA TREATMENT MARKET DYNAMICS
4.1. Drivers
4.1.1. Economic Drivers
4.1.2. Demand Side Drivers
4.1.3. Supply Side Drivers
4.2. Restraints
4.3. Opportunities/Unmet Needs of the Market
4.4. Trends
5. UNIQUE FEATURES OF THE REPORT
5.1. Competition analysis
5.2. Regulatory landscape
5.3. PESTLE analysis
5.4. Porter’s analysis
6. GLOBAL ALOPECIA TREATMENT MARKET ANALYSIS, BY ALOPECIA TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Alopecia Areata
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.2. Alopecia Totalis
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.3. Others Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.3.1. Year-over-Year (Y-o-Y) Growth Analysis (%)
7. GLOBAL ALOPECIA TREATMENT MARKET ANALYSIS, BY TREATMENT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Topical Drugs (Creams, Oils, Lotions, Gels, Shampoos and Foams)
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.2. OTC
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.3. Injectable (Platelet Rich Plasma Therapy, Steroids, Injectable Fillers)
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8. GLOBAL ALOPECIA TREATMENT MARKET FORECAST, BY END USER ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. Hospitals
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.2. Dermatology and Trichology Clinics
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.3. Home Care Settings
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.4. Aesthetic Clinics
8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9. ALOPECIA TREATMENT MARKET ANALYSIS, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1. North America Alopecia Treatment Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
9.1.1. Alopecia Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.1.1.1. Alopecia Areata
9.1.1.2. Alopecia Totalis
9.1.1.3. Others
9.1.2. Treatment Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.1.2.1. Topical Drugs (Creams, Oils, Lotions, Gels, Shampoos and Foams)
9.1.2.2. Oral Drugs
9.1.2.3. Injectable (Platelet Rich Plasma Therapy, Steroids, Injectable Fillers)
9.1.3. End User Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.1.3.1. Hospitals
9.1.3.2. Dermatology and Trichology Clinics
9.1.3.3. Home Care Settings
9.1.3.4. Aesthetic Clinics
9.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.1.4.1. U.S.
9.1.4.2. Canada
9.2. Europe Alopecia Treatment Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
9.2.1. Alopecia Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.2.1.1. Alopecia Areata
9.2.1.2. Alopecia Totalis
9.2.1.3. Others
9.2.2. Treatment Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.2.2.1. Topical Drugs (Creams, Oils, Lotions, Gels, Shampoos and Foams)
9.2.2.2. Oral Drugs
9.2.2.3. Injectable (Platelet Rich Plasma Therapy, Steroids, Injectable Fillers)
9.2.3. End User Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.2.3.1. Hospitals
9.2.3.2. Dermatology and Trichology Clinics
9.2.3.3. Home Care Settings
9.2.3.4. Aesthetic Clinics
9.2.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.2.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.2.5.1. U.K
9.2.5.2. Germany
9.2.5.3. France
9.2.5.4. Italy
9.2.5.5. Spain
9.2.5.6. Russia
9.2.5.7. Poland 9.2.5.8. Rest of Europe
9.3. Asia-Pacific Alopecia Treatment Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
9.3.1. Alopecia Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.3.1.1. Alopecia Areata
9.3.1.2. Alopecia Totalis
9.3.1.3. Others
9.3.2. Treatment Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.3.2.1. Topical Drugs (Creams, Oils, Lotions, Gels, Shampoos and Foams)
9.3.2.2. Oral Drugs
9.3.2.3. Injectable (Platelet Rich Plasma Therapy, Steroids, Injectable Fillers)
9.3.3. End User Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.3.3.1. Hospitals
9.3.3.2. Dermatology and Trichology Clinics
9.3.3.3. Home Care Settings
9.3.3.4. Aesthetic Clinics
9.3.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.3.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.3.5.1. Japan
9.3.5.2. China
9.3.5.3. India
9.3.5.4. ASEAN
9.3.5.5. Australia & New Zealand 9.3.5.6. Rest of Asia-Pacific
9.4. Latin America Acne Treatment Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
9.4.1. Alopecia Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.4.1.1. Alopecia Areata
9.4.1.2. Alopecia Totalis
9.4.1.3. Others
9.4.2. Treatment Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.4.2.1. Topical Drugs (Creams, Oils, Lotions, Gels, Shampoos and Foams)
9.4.2.2. Oral Drugs
9.4.2.3. Injectable (Platelet Rich Plasma Therapy, Steroids, Injectable Fillers)
9.4.3. End User Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.4.3.1. Hospitals
9.4.3.2. Dermatology and Trichology Clinics
9.4.3.3. Home Care Settings
9.4.3.4. Aesthetic Clinics
9.4.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.4.4.1. Brazil
9.4.4.2. Mexico
9.4.4.3. Argentina
9.4.4.4. Venezuela
9.4.4.5. Rest of Latin America
9.5. Middle East & Africa (MEA) Alopecia Treatment Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
9.5.1. Alopecia Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.5.1.1. Alopecia Areata
9.5.1.2. Alopecia Totalis
9.5.1.3. Others
9.5.2. Treatment Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.5.2.1. Topical Drugs (Creams, Oils, Lotions, Gels, Shampoos and Foams)
9.5.2.2. Oral Drugs
9.5.2.3. Injectable (Platelet Rich Plasma Therapy, Steroids, Injectable Fillers)
9.5.3. End User Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.5.3.1. Hospitals
9.5.3.2. Dermatology and Trichology Clinics
9.5.3.3. Home Care Settings
9.5.3.4. Aesthetic Clinics
9.5.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.5.4.1. Gulf Cooperation Council (GCC) Countries
9.5.4.2. Israel
9.5.4.3. South Africa
9.5.4.4. Rest of MEA
10. COMPETITION LANDSCAPE
10.1. Strategic Dashboard of Top Market Players
10.2. Company Profiles (Introduction, Financial Analysis, Alopecia & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
10.2.1. Cellmid Ltd. (Australia)
10.2.2. Cipla Ltd. (India)
10.2.3. Dr. Reddy’s Laboratories Ltd. (India)
10.2.4. Johnson & Johnson Services, Inc. (U.S)
10.2.5. Merck & Co., Inc. (U.S)
10.2.6. Phyto Ales Group (France)
10.2.7. Shiseido Co., Ltd.(Japan)
10.2.8. Sun Pharmaceutical Industries Ltd. (India)
10.2.9. Taisho Pharmaceutical Holdings Co., Ltd (Japan)
10.2.10. Teva Pharmaceutical Industries Ltd. (Israel)
10.2.11. The Himalaya Drug Company (India)
10.2.12. Vitabiotics (U.K)
